LAZZARATO, Loretta
 Distribuzione geografica
Continente #
NA - Nord America 5.499
EU - Europa 3.337
AS - Asia 1.250
AF - Africa 28
SA - Sud America 25
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.165
Nazione #
US - Stati Uniti d'America 5.425
CN - Cina 826
IT - Italia 762
DE - Germania 518
IE - Irlanda 485
SE - Svezia 317
UA - Ucraina 227
FR - Francia 169
AT - Austria 161
FI - Finlandia 148
PL - Polonia 140
GB - Regno Unito 139
DK - Danimarca 130
KR - Corea 113
VN - Vietnam 77
CA - Canada 66
IN - India 58
JP - Giappone 52
BE - Belgio 50
TR - Turchia 24
RU - Federazione Russa 21
HK - Hong Kong 19
NL - Olanda 18
SG - Singapore 15
SN - Senegal 15
AU - Australia 14
BR - Brasile 13
CH - Svizzera 13
UZ - Uzbekistan 10
ES - Italia 9
TW - Taiwan 9
IR - Iran 8
MX - Messico 8
EG - Egitto 7
EU - Europa 7
JO - Giordania 7
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
GR - Grecia 5
TH - Thailandia 5
ID - Indonesia 4
IQ - Iraq 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AR - Argentina 3
BG - Bulgaria 3
HR - Croazia 3
PE - Perù 3
RO - Romania 3
ZA - Sudafrica 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
CL - Cile 2
DZ - Algeria 2
EC - Ecuador 2
HU - Ungheria 2
MY - Malesia 2
NO - Norvegia 2
PK - Pakistan 2
UY - Uruguay 2
CY - Cipro 1
IL - Israele 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PH - Filippine 1
PW - Palau 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 10.165
Città #
Ann Arbor 698
Chandler 609
Fairfield 541
Dublin 481
Beijing 422
Ashburn 377
Woodbridge 268
Torino 252
Houston 244
Seattle 209
Wilmington 209
Cambridge 169
Jacksonville 166
Vienna 159
Pisa 146
Dearborn 136
Warsaw 131
Nyköping 126
Frankfurt am Main 124
Medford 108
Princeton 104
Villeurbanne 104
Redwood City 77
Fremont 60
Brussels 50
Dong Ket 43
Turin 42
Boston 38
Shanghai 36
San Diego 34
Milan 33
Nanjing 32
Hangzhou 29
Munich 28
Boardman 26
Guangzhou 26
Ottawa 25
Toronto 24
Washington 23
Wuhan 22
New York 18
Norwalk 18
Zhengzhou 18
Hefei 13
Phoenix 13
Siena 13
Jinan 12
Pune 12
Shenyang 12
Changsha 11
Falls Church 11
Rome 11
Verona 11
Bologna 10
Helsinki 10
Nürnberg 10
Tokyo 10
Leinì 9
Silver Spring 9
Chengdu 8
Fuzhou 8
Kunming 8
London 8
Monmouth Junction 8
Buffalo 7
Central District 7
Copenhagen 7
Dallas 7
Nanchang 7
Upper Marlboro 7
Xian 7
Changchun 6
Florence 6
Hebei 6
Seoul 6
Taipei 6
Toledo 6
Amman 5
Ardabil 5
Catania 5
Hanover 5
Lachine 5
Nashville 5
Nottingham 5
Paris 5
Rivoli 5
Tianjin 5
Ankara 4
Atripalda 4
Cairo 4
Carmagnola 4
Dresden 4
Fort Lauderdale 4
Harbin 4
Hong Kong 4
Istanbul 4
Kharkiv 4
Legnano 4
Memphis 4
Montichiari 4
Totale 6.889
Nome #
Quinone based nitric oxide donating compounds 477
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance 396
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells 298
New furoxan derivatives for the treatment of ocular hypertension 265
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors. 258
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. 257
Doxorubicin-antioxidant multitarget drugs 242
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 200
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery 179
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis 172
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis 166
New nitric oxide or hydrogen sulfide releasing aspirins 164
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs 162
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity 156
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents 155
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 154
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light 154
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 148
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. 147
Combination of PDT and NOPDT with a tailored BODIPY derivative 147
Anti-pseudomonas activity of 3-nitro-4-phenylfuroxan 144
A rapid screening for cytochromes P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives 144
Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells 140
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth 139
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 137
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension 135
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 130
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties 129
A Potent and Selective P-gp Modulator for Altering Multidrug Resistance Due to Pump Overexpression 128
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 126
Synthesis and biological evaluation of the first example of NO-donor histone deacetylase inhibitor 126
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid 124
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs 123
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion 122
Amphiphilic NO-Donor Antioxidants 120
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties 115
Multitarget Drugs: Focus on the NO-donor hybrid drugs 114
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae 114
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization 114
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 113
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 108
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 106
Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors 105
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light 104
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations 102
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 99
A new class of ibuprofen derivatives with reduced gastrotoxicity 96
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 96
A novel hybrid aspirin-NO releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages 96
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 95
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor 95
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells 93
DNA-targeted NO release photoregulated by green light 91
Mechanistic insights into cyclooxygenase irreversible inactivation byaspirin 89
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. 84
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1 83
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug 79
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 77
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 77
Amphiphile NO-donor antioxidants as polivalent drugs 76
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 74
Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin 71
A NEW CLASS OF BISPHOSPHONATES WITH NO-DONOR PROPERTIES 70
Novel water soluble furoxan derivatives having antitumor activity 69
GIFC-2018 - BOOK OF ABSTRACTS 68
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models 64
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs 63
Can we exploit β-lactamases intrinsic dynamics for designing more effective inhibitors? 63
Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity 60
Salicilic acid derivatives 58
New class of NO-donor soluble aspirins 56
Furoxan nitric oxide donors disperse Pseudomonas aeruginosa biofilms, accelerate growth, and repress pyoverdine production 55
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY 54
NO donor - melatonins: a new class of potential antiatherosclerosis agents 53
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib 52
nitric oxide furoxan derivative compounds endowed with antitumoral activity 51
Synthesis of NO-Donor Bisphosphonates and Their in Vitro Action on Bone Resorption 50
New NO-donor Bisphosphonates 48
NEW CLASS OF NO-DONORS WITH BONE SELECTIVITY 47
Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers 47
New No-donor aspirin derivatives 45
Structure-Antioxidant Activity Relationships in a Series of NO-Donor Phenols 44
Enhancing doxorubicin anticancer activity with a novel polymeric platform photoreleasing nitric oxide 44
Studies of the potential genotoxic effects of furoxans: the case of CAS 1609 and of the water soluble analogue of CHF 2363 41
Physicochemical profile and in vitro permeation behavior of a new class of non-steroidal anti-inflammatory drug candidates 39
BROAD SPECTRUM METALLO beta-LACTAMASES INHIBITORS: NEW TOOLS AGAINST CLINICALLY-RELEVANT CARBAPENEMASES 38
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 38
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities 38
Michael addition of Grignard reagents to tetraethyl ethenylidenebisphosphonate 36
A generator of peroxynitrite activatable with red light 34
Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells 34
NO-donor aspirin derivatives 32
Farmaci antiinfiammatori non steroidei 31
NO release regulated by doxorubicin as the green light-harvesting antenna 25
Cryo-EM structures of staphylococcal IsdB bound to human hemoglobin reveal the process of heme extraction 22
Multitarget antioxidant NO-donor organic nitrates: a novel ap-proach to overcome nitrates tolerance, an ex vivo study 22
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors 16
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage 15
Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs 9
New lipophilic organic nitrates: Candidates for chronic skin disease therapy 9
Totale 10.470
Categoria #
all - tutte 24.856
article - articoli 0
book - libri 0
conference - conferenze 3.027
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019647 0 0 0 0 0 0 0 0 37 130 345 135
2019/20201.909 68 64 120 235 130 237 202 160 223 207 150 113
2020/20211.314 120 99 88 82 118 82 82 92 174 133 72 172
2021/20221.634 134 91 113 149 91 57 116 107 76 91 349 260
2022/20231.888 173 173 54 160 148 433 279 96 173 75 78 46
2023/2024784 120 142 68 72 92 173 42 57 18 0 0 0
Totale 10.503